Patel M, Jimeno A, Wang D, Stemmer S, Bauer T, Sweis R, et al
Read full disclaimer Cagrilintide is a synthetic long-acting amylin receptor agonist studied in research into amylin-receptor signalling and metabolic-regulation pathways in experimental models
They hypothesized that if glutathione deficiency could be corrected it would result in an increase in life span
Gastrointestinal adverse events occurred in 79.6% of CagriSema participants versus 39.9% with placebo, were mostly transient, and led to discontinuation in 6-8.4% of participants
By mining gene expression profile data, mutation data and other relevant information, differential genes and proteins closely related to cancer occurrence and development can be screened, which may serve as potential drug targets and prognostic biomarkers, providing key clues for the precise treatment of cancer (Xu et al., 2021
Available from: A